
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 930 | 912 | 1033 | 1121 | 1348 | 1229 |
Fund Return | -7.02% | -8.83% | 3.33% | 3.88% | 6.15% | 2.09% |
Place in category | 3142 | 3088 | 1421 | 623 | 496 | 518 |
% in Category | 88 | 85 | 40 | 24 | 25 | 47 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Adamant Medtech B EUR | 1.46B | -6.43 | 2.05 | 8.81 | ||
Adamant Medtech I EUR | 1.46B | -6.21 | 2.77 | 9.59 | ||
Adamant Medtech T EUR | 1.46B | -6.30 | 2.46 | 9.25 | ||
Bellevues Lux BB Adamant Medtech HB | 1.46B | 0.38 | 1.83 | 7.02 | ||
LU1477743386 | 310.05M | -5.34 | -3.16 | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Flossbach von Storch S Multiple Ope | 24.52B | -1.33 | 2.29 | 4.27 | ||
Flossbach von Storch S Multiple Opf | 24.52B | -1.33 | 3.04 | 5.24 | ||
Flossbach von Storch S Multiple Opi | 24.52B | -1.11 | 2.98 | 4.92 | ||
LU1663838545 | 14.52B | -0.23 | 2.65 | - | ||
Flossbach von Storch Multiple Oppoi | 10.88B | -1.41 | 2.39 | 4.66 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
SPDR S&P 500 UCITS | IE00B6YX5C33 | 13.95 | 446.77 | +0.57% | |
Xtrackers MSCI USA UCITS ETF 1C | IE00BJ0KDR00 | 8.23 | 155.76 | +0.78% | |
Xtrackers MSCI Emerging Markets UCITS | IE00BTJRMP35 | 6.02 | 55.836 | +0.25% | |
Italy (Republic Of) 0% | IT0005592370 | 3.26 | - | - | |
Italy 0 13-Jun-2025 | IT0005599474 | 3.25 | 99.874 | +0.04% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Strong Buy |
Technical Indicators | Strong Buy | BUY | Strong Buy |
Summary | Strong Buy | Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review